Cargando…

Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model

The limited effect of current medications on neuropathic pain (NP) has initiated large efforts to develop effective treatments. Animal studies showed that glycine transporter (GlyT) inhibitors are promising analgesics in NP, though concerns regarding adverse effects were raised. We aimed to study NF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammadzadeh, Amir, Lakatos, Péter P., Balogh, Mihály, Zádor, Ferenc, Karádi, Dávid Árpád, Zádori, Zoltán S., Király, Kornél, Galambos, Anna Rita, Barsi, Szilvia, Riba, Pál, Benyhe, Sándor, Köles, László, Tábi, Tamás, Szökő, Éva, Harsing, Laszlo G., Al-Khrasani, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957511/ https://www.ncbi.nlm.nih.gov/pubmed/33804568 http://dx.doi.org/10.3390/ijms22052479

Ejemplares similares

Synergistic Control of Transmitter Turnover at Glycinergic Synapses by GlyT1, GlyT2, and ASC-1
por: Eulenburg, Volker, et al.
Publicado: (2022)

GlyT2+ Neurons in the Lateral Cerebellar Nucleus
por: Uusisaari, Marylka, et al.
Publicado: (2009)

Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies
por: Zafra, Francisco, et al.
Publicado: (2016)

Calnexin-Assisted Biogenesis of the Neuronal Glycine Transporter 2 (GlyT2)
por: Arribas-González, Esther, et al.
Publicado: (2013)

Bidirectional Modulation of Nociception by GlyT2(+) Neurons in the Ventrolateral Periaqueductal Gray
por: Assareh, Neda, et al.
Publicado: (2023)

Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain
por: Király, Kornél, et al.
Publicado: (2021)

The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo
por: de la Rocha-Muñoz, Andrés, et al.
Publicado: (2021)

Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2
por: Frangos, Zachary J, et al.
Publicado: (2023)

Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate
por: Zádor, Ferenc, et al.
Publicado: (2020)

Identification of a 3(rd) Na(+) Binding Site of the Glycine Transporter, GlyT2
por: Subramanian, Nandhitha, et al.
Publicado: (2016)

Glycinergic Transmission in the Presence and Absence of Functional GlyT2: Lessons From the Auditory Brainstem
por: Brill, Sina E., et al.
Publicado: (2021)

Pregabalin–Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats
por: Essmat, Nariman, et al.
Publicado: (2023)

Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene
por: Gill, Jennifer L., et al.
Publicado: (2011)

PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination
por: Barrera, Susana P., et al.
Publicado: (2015)

Correction: Identification of a 3(rd) Na(+) Binding Site of the Glycine Transporter, GlyT2
por: Subramanian, Nandhitha, et al.
Publicado: (2016)

The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain
por: Armbruster, Anja, et al.
Publicado: (2018)

Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies
por: Rosenbrock, Holger, et al.
Publicado: (2018)

Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics
por: Mostyn, Shannon N, et al.
Publicado: (2019)

The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action
por: Lakatos, Péter P., et al.
Publicado: (2022)

Further characterization of the GlyT-1 inhibitor Org25935: anti-alcohol, neurobehavioral, and gene expression effects
por: Lidö, Helga Höifödt, et al.
Publicado: (2017)

MS Binding Assays for Glycine Transporter 2 (GlyT2) Employing Org25543 as Reporter Ligand
por: Ackermann, Thomas M., et al.
Publicado: (2020)

Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia
por: Rosenbrock, Holger, et al.
Publicado: (2023)

Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial
por: Wunderlich, Glen, et al.
Publicado: (2023)

Constitutive Endocytosis and Turnover of the Neuronal Glycine Transporter GlyT2 Is Dependent on Ubiquitination of a C-Terminal Lysine Cluster
por: de Juan-Sanz, Jaime, et al.
Publicado: (2013)

Expression of functional inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 by astrocytes of inferior colliculus and hippocampus
por: Ghirardini, Elsa, et al.
Publicado: (2018)

Modification of a Putative Third Sodium Site in the Glycine Transporter GlyT2 Influences the Chloride Dependence of Substrate Transport
por: Benito-Muñoz, Cristina, et al.
Publicado: (2018)

E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2
por: de la Rocha-Muñoz, A., et al.
Publicado: (2019)

Molecular and Electrophysiological Characterization of Dorsal Horn Neurons in a GlyT2-iCre-tdTomato Mouse Line
por: He, Xiaolan, et al.
Publicado: (2021)

Bupivacaine reduces GlyT1 expression by potentiating the p-AMPKα/BDNF signalling pathway in spinal astrocytes of rats
por: Lu, Kaimei, et al.
Publicado: (2022)

On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance
por: Fürst, Susanna, et al.
Publicado: (2020)

Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats
por: Karádi, David Á., et al.
Publicado: (2023)

Maternal Separation Alters Ethanol Drinking and Reversal Learning Processes in Adolescent Rats: The Impact of Sex and Glycine Transporter Type 1 (GlyT1) Inhibitor
por: Filarowska-Jurko, Joanna, et al.
Publicado: (2022)

Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
por: Merk, Wojciech, et al.
Publicado: (2019)

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia
por: El fadili, Mohamed, et al.
Publicado: (2022)

GlyT2-Dependent Preservation of MECP2-Expression in Inhibitory Neurons Improves Early Respiratory Symptoms but Does Not Rescue Survival in a Mouse Model of Rett Syndrome
por: Hülsmann, Swen, et al.
Publicado: (2016)

Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics
por: Moschetti, Viktoria, et al.
Publicado: (2018)

Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats
por: Balogh, Mihály, et al.
Publicado: (2019)

Reduction of Rapid Proliferating Tumour Cell Lines by Inhibition of the Specific Glycine Transporter GLYT1
por: Bierhals, Christine Garcia, et al.
Publicado: (2021)

Recent Molecular Insights into Agonist-specific Binding to the Mu-Opioid Receptor
por: Zádor, Ferenc, et al.
Publicado: (2022)

The tripeptide N-Cbz-βGly-Gly-Gly-Obz
por: Nicholas, Sumesh
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4rjgq22unqv1v3mfj79mt4i0bf